Related Experiment Videos
Chromosomal beta-lactam resistance in enterobacteria
Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1986
Summary
Mutations in the ampD gene frequently cause high-level production of ampC beta-lactamase in certain bacteria. This leads to clinical resistance against third-generation cephalosporins.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Most enterobacteria possess a chromosomal ampC beta-lactamase gene.
- In Escherichia coli and Shigella, ampC expression is non-inducible, resulting in low beta-lactamase levels.
- Resistance to modern cephalosporins is rare in these species due to infrequent mutations.
Purpose of the Study:
- To investigate the regulation of ampC beta-lactamase expression in enterobacteria.
- To understand the genetic basis of cephalosporin resistance in species with inducible ampC.
- To identify key genes involved in ampC regulation and their impact on resistance.
Main Methods:
- Analysis of ampC gene expression in various enterobacterial species.
- Genetic studies involving mutations in ampR and ampD regulatory genes.
- Assessment of beta-lactamase inducibility and production levels.
Main Results:
- In Enterobacter cloacae and Citrobacter freundii, ampC expression is induced by beta-lactams and regulated by ampR and ampD.
- Mutations in ampR eliminate beta-lactamase inducibility, leading to low constitutive levels.
- Mutations in ampD, with an intact ampR, cause high-frequency, constitutive overproduction of ampC beta-lactamase.
Conclusions:
- AmpD mutations are a frequent cause of clinical resistance to third-generation cephalosporins in enterobacteria with inducible ampC.
- The ampR and ampD genes play critical roles in the regulation of ampC beta-lactamase.
- Understanding these regulatory mechanisms is crucial for combating antibiotic resistance.